AU Patent

AU2022201290B2 — Compositions and methods for treating renal failure

Assigned to La Jolla Pharmaceutical Co · Expires 2024-06-13 · 2y expired

What this patent protects

The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.

USPTO Abstract

The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022201290B2
Jurisdiction
AU
Classification
—
Expires
2024-06-13
Drug substance claim
No
Drug product claim
No
Assignee
La Jolla Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.